Companies / Germany

Merck KGaA To Divest Generics Business?

January 2007 | Company Finance Alert

German drugmaker

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

Industry / Germany BMI View: In line with the industry trend for multinational pharmaceutical companies, Boehringer Ingelheim had a difficult year in 2010. The reduction in the company's net profit in the year was substantial,...

April 2011

Bayer Cuts Costs To Focus On Innovation And Emerging Markets

Industry / Germany BMI Core View: Pharmaceutical sales forces will contract in developed states and expand in emerging markets. The primary cause of this trend is the declining influence of US and Western European doctors...

December 2010

Merck Serono Board Reshuffle Should Not Dramatically Change Strategic Direction

Industry / Germany BMI View: Despite some disappointing verdicts from regulators on promising drug prospects, Merck Serono's long-term strategy - investing in research, embracing personalised medicine, management of a diversified...

December 2010

Investment In Innovation Necessary

Industry / Israel The Israeli pharmaceutical market is still in favour of patented medicines, despite the presence of one of the world's largest generic drugmakers, Teva Pharmaceuticals . Patented drugs accounted for...

May 2010

Investment In Innovation Necessary

May 2010